- Home
- BMRN vs RRX Comparison
BMRN vs RRX Comparison
Compare BMRN & RRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BMRN | RRX |
|---|---|---|
| Founded | 1996 | 1955 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.3B | 10.0B |
| IPO Year | 1999 | 1994 |
Fundamental Metrics
Financial Performance| Metric | BMRN | RRX |
|---|---|---|
| Price | $56.74 | $180.67 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 28 | 11 |
| Target Price | $90.78 | ★ $232.20 |
| AVG Volume (30 Days) | ★ 2.4M | 1.2M |
| Earning Date | 11-02-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 0.77% |
| EPS Growth | N/A | ★ 42.86 |
| EPS | 0.14 | ★ 2.52 |
| Revenue | $1,313,646,000.00 | ★ $3,257,100,000.00 |
| Revenue This Year | $20.05 | $4.75 |
| Revenue Next Year | $14.91 | $12.96 |
| P/E Ratio | $415.29 | ★ $72.59 |
| Revenue Growth | ★ 17.62 | 5.21 |
| 52 Week Low | $49.26 | $127.96 |
| 52 Week High | $70.98 | $247.80 |
Technical Indicators
Market Signals| Indicator | BMRN | RRX |
|---|---|---|
| Relative Strength Index (RSI) | 48.45 | 61.23 |
| Support Level | $53.19 | $177.96 |
| Resistance Level | $58.39 | $221.59 |
| Average True Range (ATR) | 1.85 | 8.86 |
| MACD | 0.33 | 2.45 |
| Stochastic Oscillator | 63.97 | 81.75 |
Price Performance
Historical ComparisonAbout BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About RRX Regal Rexnord Corporation
Regal Rexnord Corp is in the engineering and manufacturing of industrial powertrain solutions, power transmission components, electric motors, electronic controls, air-moving products, and specialty electrical components and systems, serving customers around the world. The three operating segments include Automation & Motion Control (AMC) segment; Industrial Powertrain Solutions (IPS) segment, which derives maximum revenue; and Power Efficiency Solutions (PES) segment. Geographically, the company operates in North America, Europe, Asia, and Rest of the world, of which it derives maximum revenue from North America.